ARCHIVES

Beta Blockers Negate Harmful Recurrence Risks of ACE Inhibitors

This article is from The Cancer Letter archive.

Vol. 34 No. 4 | April 29, 2011

Download PDF Visit The Full Archive

Related Articles

DRCCA Board Votes To End Support For CCPDS July 31, 1983

May 14, 1982

President’s Cancer Panel annual report finds barriers in translational research stall progress.

July 8, 2005

NIH Awards 24 More Grants For Women’s Health Initiative

October 14, 1994

In Brief: FDA To Review Preclinical Testing, Phase I Protocols At Open Advisory Group Meeting

November 14, 1975

Oblimersen Combination Improves CLL Survival

December 28, 2007

Analysis Finds Exercise Lowers Colon Cancer Risk

February 27, 2009